TUNGKOL SA EPISODE NA ITO

Ingles
Estados Unidos

KOPYA NG SALIN 🔗

I-SEARCH ANG MGA NAKARAANG EPISODE

I-search ang mga nakaraang episode ng Taylor & Francis.

IBA PANG MGA EPISOD SA PODCAST NA ITO

In this interview, Imogen Locke (The Royal Marsden NHS Foundation Trust, UK) discusses the evolving role of stereotactic ablative radiotherapy (SABR) in oligometastatic and oligoprogressive breast cancer. Locke explains the distinction between these two clinical scenarios, how timing and patient s…
Christopher Lieu, co-director of gastrointestinal medical oncology and the associate director for clinical research at the University of Colorado Cancer Center (CO, USA) discusses the importance of biomarker testing in metastatic colorectal cancer to inform personalized patient care.
The patient authors with over 48 years of combined real-world experience with chronic myeloid leukemia, and a healthcare professional, use their own personal experiences to describe the factors that may affect the patient–doctor relationship, patient care and outcomes. The authors believe that this…
Over the past two decades, HER2-positive breast cancer has undergone a dramatic transformation in oncology. In this interview, Cristina Saura (Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Spain) reflects on witnessing this evolution firsthand, from the introduction of …
First-line management of unresectable hepatocellular carcinoma: clinical perspectives from the CheckMate 9DW study by Taylor & Francis Group
Paunawa: Ang podcast at artwork na naka-embed sa page na ito ay mula sa Taylor & Francis Group, na pag-aari ng may-ari nito at hindi kaakibat o ineendorso ng Listen Notes, Inc.